Chong Kun Dang Holdings Corp. (KRX:001630)
South Korea · Delayed Price · Currency is KRW 48,500
+900 (1.89%)
At close: Nov 26, 2025
Chong Kun Dang Holdings Market Cap
Chong Kun Dang Holdings has a market cap or net worth of 230.89 billion as of November 26, 2025. Its market cap has decreased by -12.45% in one year.
Market Cap
230.89B
Enterprise Value
947.70B
Revenue
950.10B
Ranking
n/a
PE Ratio
6.65
Stock Price
48,500.00
Market Cap Chart
Since July 9, 1992, Chong Kun Dang Holdings's market cap has increased from 43.10B to 230.89B, an increase of 435.67%. That is a compound annual growth rate of 5.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 226.60B | -0.21% |
| Dec 30, 2024 | 227.08B | -19.63% |
| Dec 28, 2023 | 282.55B | 9.42% |
| Dec 29, 2022 | 258.23B | -31.93% |
| Dec 30, 2021 | 379.33B | -40.61% |
| Dec 30, 2020 | 638.76B | 26.24% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.32T |
| Celltrion | 39.84T |
| ALTEOGEN | 27.70T |
| SK Biopharmaceuticals | 10.10T |
| ABL Bio | 9.54T |
| Yuhan | 8.55T |
| Peptron | 7.43T |
| LigaChem Biosciences | 6.25T |